Insider selling at Azenta, even at a lower share price, implies they considered it reasonable. Despite some alignment with common shareholders, the lack of insider buying over the past year is discouraging.
The elevated P/S ratio of Azenta shows the market's faith in its capacity to weather global industry headwinds. This is why Azenta's P/S ratio outpaces most other firms. Shareholder sentiment may remain steady barring any shift in these circumstances.
Azenta stock may not be an optimal investment now considering the negative growth outlook and fair valuation. Its high beta could offer future trades if market conditions change.
The large sales by insiders, even at a price below the current rate, are seen as a potentially discouraging sign. However, insiders owning a reasonable chunk of the company indicates an alignment of interests with other shareholders.
Despite Azenta's falling revenues and non-profitability, the stock has delivered respectable returns. The link between past revenue performance and share price remains murky. A recent uptick in one-year TSR Vs five-year TSR suggests potentially growing business momentum.
Azenta股票討論區
專欄US Top Gap Ups and Downs on 8/9: AZTA, TOST, DOCS, RBLX and More
Gap Ups
1. $Azenta(AZTA.US)$ - up 14.9%
2. $Toast(TOST.US)$ - up 12.1%
3. $Celsius Holdings(CELH.US)$ - up 9.6%
4. $Axon Enterprise(AXON.US)$ - up 9.2%
5. $Marqeta(MQ.US)$ - up 7.6%
6. $阿克邁(AKAM.US)$ - up 6.1%
7. $Coupang(CPNG.US)$ - up 5.8%
8. $佩恩國民博彩(PENN.US)$ - up 5.3%
9...
專欄US Top Gap Ups and Downs on 7/13: JD, DB, PGR, INFY and More
Gap Ups
1. $韓國電力(KEP.US)$ - up 2.9%
2. $Pilgrim's Pride(PPC.US)$ - up 2.6%
3. $The Trade Desk(TTD.US)$ - up 2.0%
4. $Sibanye Stillwater(SBSW.US)$ - up 1.9%
5. $力拓(RIO.US)$ - up 1.8%
6. $印孚瑟斯(INFY.US)$ - up 1.8%
7. $京東(JD.US)$ - up 1.7%
8. $德意志銀行(DB.US)$ - up 1.7%...
11/15 Watchlist
專欄Today's pre-market stock movers: TSLA, JPM, NVAX, CAG and more
• $Theravance Biopharma(TBPH.US)$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma(AMYT.US)$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners(GRBK.US)$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy(TGA.US)$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
暫無評論